Transformative year with strong progress on revenue
Draslovka a.s., a leading specialty chemicals company, announces its financial results for the year ended 31 December 2022.
Financial highlights
• Significant revenue growth of 286% to US$468m (2021: US$121.3m) following transformative acquisitions
• US$150m equity injection through strategic partnership with Oaktree Capital
Operational highlights
Pavel Bruzek, CEO of Draslovka, commented:
“I am proud of the significant transformation we achieved in 2022. Despite the macro challenges, Draslovka became a new company through transformative acquisitions, including securing exclusive rights to GLT, and today we are on our way to becoming a leader in the mining sector supply chain. I am excited about the future and how we will harness GLT’s ability to address the three biggest challenges facing the mining industry: sustainability, profitability and securing social license to operate. GLT has received widespread interest from gold, nickel, cobalt and copper miners, including the likes of Barrick Gold.
“The next step is to continue to build out our suite of offerings and become a cornerstone solutions provider to the mining, agriculture and speciality chemicals sectors. This will be driven by selective acquisitions as well as in-house R&D.
“I look forward to announcing further commercial deals in the coming months and thank the team at Draslovka for making 2022 a great year.”
Outlook
The Company’s growth prospects will be supported through outside funding. Management is currently exploring financing options to provide capital to continue to grow the business.
Financial performance
In thousands of US dollars | 2022 | 2021 | Change |
---|---|---|---|
Revenue | 468,031 | 121,344 | + 286% |
Gross profit | 4,688 | 14,468 | - 68% |
Adj. EBITDA | 77,300 | 89,300 | - 13% |
Free cash flow | 7,900 | 24,600 | - 68% |
About Draslovka
Draslovka Holdings a.s. (‘Draslovka’) is a global leader in cyanide-based chemical specialties and agricultural chemicals including next generation fumigants and biocides. Utilising the company’s significant expertise, Draslovka develops and scales solutions which are vital for delivering sustainable growth at pace. A private holding company based in the Czech Republic, it is owned by four Czech families and has more than 100 years of experience in hydrogen cyanide (HCN) production and HCN chemistry. The company specializes in the production of fully synthetic and highly purified liquid HCN, which undergoes further processing for application in a variety of downstream products ranging from the mining through to agriculture sectors. Through its scalable chemistry-based solutions, Draslovka aims to unlock transformation and be the leading global player in the production of cyanides for use in synthesis, mining, and industrial and agricultural applications, with safety and environmental sustainability at the heart of all its operations.
Contacts
Investor Enquiries
Draslovka Holding a.s.
Martin Simonek
Head of Investor Relations
Email: martin.simonek@draslovka.com
Media Enquiries
Draslovka Holding a.s.
Erik Svamberk
Head of Public Affairs
Tel: +420 723 893 400
Email: eril.svamberk@draslovka.com
FTI Consulting
Viktor Pomichal / Ariadna D. Peretz
Tel: +44 (0) 7890 417764
Email: draslovka@fticonsulting.com